A key enabler of digital transformation
According to the Tufts Center for the Study of Drug Development, developing a prescription drug that gains market approval costs $2.6 billion and is expected to reach $32 billion by 2050 considering the industry’s current pace.
The cost and timelines to research and develop new drugs are consistently rising and this, on top of other challenges, like more stringent regulatory approvals, is pushing companies to re-examine their operational models and look for process automation technologies.
Robotic Process Automation (RPA) has tremendous potential when it comes to clinical trials, pharmacovigilance efforts, regulatory compliance and other back office operations, and allows companies to bring drugs to market on an accelerated timeline.
Attend this webinar to hear industry experts speak about the RPA use cases in life sciences and its positive impact on operational efficiency and costs. The event is jointly organized by Nividous and Kinapse, now a part of Syneos Health, the world’s only fully integrated biopharma solutions organization.
John has 30 years’ experience in the biopharma industry. He has held global leadership positions in R&D IT, IT Shared Services and Chief Technology Officer roles, and been responsible for the delivery of major technology enabled organisational transformations in Regulatory, Pharmacovigilance, Clinical, Medical Affairs, IT and Global Business Services.